75F40125C00098
Definitive Contract
Overview
Government Description
DO LABORATORY PRESCRIBED AND AD LIBITUM USE SESSIONS REPRESENT REAL-WORLD ENDS USE
Awarding / Funding Agency
PSC
Place of Performance
Rochester, NY 14623 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
6
Related Opportunity
None
Rochester Institute Of Technology was awarded
Definitive Contract 75F40125C00098 (75F401-25-C-00098)
for Do Laboratory Prescribed And Ad Libitum Use Sessions Represent Real-World Ends Use
worth up to $4,511,759
by the FDA Office of Acquisition and Grant Services
in September 2025.
The contract
has a duration of 4 years and
was awarded
full & open
with
NAICS 541715 and
PSC AJ11
via direct negotiation acquisition procedures with 1 bid received.
Status
(Open)
Last Modified 9/30/25
Period of Performance
9/30/25
Start Date
9/24/29
Current End Date
9/24/29
Potential End Date
Obligations
$4.5M
Total Obligated
$4.5M
Current Award
$4.5M
Potential Award
Award Hierarchy
Definitive Contract
75F40125C00098
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75F40125C00098
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
J6TWTRKC1X14
Awardee CAGE
0SWS3
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsjcooper1
Last Modified By
hhsjcooper1
Approved By
hhsjcooper1
Legislative
Legislative Mandates
None Applicable
Performance District
NY-25
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Joseph Morelle
Modified: 9/30/25